SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-125782
Filing Date
2019-04-29
Accepted
2019-04-29 17:30:55
Documents
3
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d734420ddefa14a.htm DEFA14A 21242
2 GRAPHIC g734420naa1.jpg GRAPHIC 144822
3 GRAPHIC g734420naa2.jpg GRAPHIC 118434
  Complete submission text file 0001193125-19-125782.txt   385058
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 19777316
SIC: 3826 Laboratory Analytical Instruments